Centile Bioscience Inc.

New Filing
CIK: 0002129392·Other Technology·DELAWARE·Filed: Apr 16, 2026
Total Offering

$4,054,996

Amount Sold

$3,054,996

Investors

3

First Sale

Mar 20, 2026

Offering Details

Type
Equity, Other: Convertible securities
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2023
Non-Accredited Investors
No

Related Persons

NameRole
Jakob Seidlitz
Richard Bethlehem
Joshua Bernstock
L. Keith Mullins
Hannah Mamuszka

Company

Centile Bioscience Inc.

5023 WISSIOMING RD.

BETHESDA, MD, 20816

240-204-0747

SEC Filing

0002129392-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free